logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Carboplatin/paclitaxel/pembrolizumabLack of efficacy: case report

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2023年 / 1938卷 / 1期
关键词:
D O I:
10.1007/s40278-023-30510-2
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:369 / 369
相关论文
共 50 条
  • [1] Carboplatin/paclitaxel/pembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1894 (1) : 95 - 95
  • [2] Carboplatin/paclitaxel/pembrolizumabLack of efficacy and antibody syndrome: case report
    Reactions Weekly, 2025, 2051 (1) : 82 - 82
  • [3] Carboplatin/paclitaxel/pembrolizumabLack of efficacy
    Reactions Weekly, 2024, 2013 (1) : 109 - 109
  • [4] Carboplatin/Paclitaxel/PembrolizumabLack of efficacy
    Reactions Weekly, 2024, 1999 (1) : 106 - 106
  • [5] Paclitaxel/pembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1918 (1) : 403 - 403
  • [6] Carboplatin/gemcitabine/pembrolizumabLack of efficacy: case report
    Reactions Weekly, 2022, 1920 (1) : 137 - 137
  • [7] Carboplatin/gemcitabine/pembrolizumabLack of efficacy: case report
    Reactions Weekly, 2023, 1959 (1) : 176 - 176
  • [8] Cisplatin/paclitaxel/pembrolizumabLack of efficacy: case report
    Reactions Weekly, 2025, 2042 (1) : 125 - 125
  • [9] Paclitaxel/pembrolizumabLack of efficacy and pulmonary arterial hypertension: case report
    Reactions Weekly, 2023, 1961 (1) : 335 - 335
  • [10] Carboplatin/gemcitabine/pembrolizumabLack of efficacy, pruritus and skin rash: case report
    Reactions Weekly, 2022, 1913 (1) : 131 - 131
← 12345 →